Viral gene therapy for head and neck cancer

Area of Science:

• Oncology
• Virology
• Biotechnology

Background:

• Viral gene therapy represents a novel treatment strategy for head and neck cancers.
• This review synthesizes current literature on viral gene therapy applications in this field.

Purpose of the Study:

• To provide a comprehensive review of viral gene therapy for head and neck cancer.
• To highlight current advancements and future directions in the field.

Main Methods:

• Literature review of viral gene therapy for head and neck cancer.
• Analysis of existing government-licensed viral gene therapy products.
• Examination of viral mechanisms targeting tumor-associated genes.

Main Results:

• Licensed viral gene therapy products are available for head and neck cancer, used alongside conventional treatments.
• Viruses are engineered to target specific tumor genes, including the p53 tumor suppressor gene.
• Oncolytic viruses demonstrate selective cancer cell destruction via replication and can be modified to carry therapeutic genes.

Conclusions:

• Significant progress has been made in viral gene therapy for head and neck cancer over four decades.
• Further research is essential to optimize viral efficacy and facilitate wider adoption in patient management.
• Enhancing viral effectiveness is key to improving outcomes for head and neck cancer patients.